|
US4188373A
(en)
|
1976-02-26 |
1980-02-12 |
Cooper Laboratories, Inc. |
Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
|
|
US4478822A
(en)
|
1983-05-16 |
1984-10-23 |
Merck & Co., Inc. |
Drug delivery system utilizing thermosetting gels
|
|
US4968507A
(en)
|
1984-06-20 |
1990-11-06 |
Merck & Co., Inc. |
Controlled porosity osmotic pump
|
|
JPH01258620A
(ja)
|
1988-04-08 |
1989-10-16 |
Dai Ichi Seiyaku Co Ltd |
耳疾患用局所製剤
|
|
US5702716A
(en)
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
US4938763B1
(en)
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
|
US5324519A
(en)
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
US5292516A
(en)
|
1990-05-01 |
1994-03-08 |
Mediventures, Inc. |
Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
|
|
IT1251151B
(it)
|
1991-08-05 |
1995-05-04 |
Fidia Spa |
Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
|
|
EP0551626A1
(en)
|
1991-12-19 |
1993-07-21 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. |
Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
|
|
US5421818A
(en)
|
1993-10-18 |
1995-06-06 |
Inner Ear Medical Delivery Systems, Inc. |
Multi-functional inner ear treatment and diagnostic system
|
|
JP3696265B2
(ja)
|
1994-02-04 |
2005-09-14 |
日本オルガノン株式会社 |
点鼻液剤
|
|
WO1995027481A1
(en)
|
1994-04-08 |
1995-10-19 |
Atrix Laboratories, Inc. |
Liquid delivery compositions
|
|
US6201065B1
(en)
|
1995-07-28 |
2001-03-13 |
Focal, Inc. |
Multiblock biodegradable hydrogels for drug delivery and tissue treatment
|
|
WO1997038698A1
(en)
|
1996-04-18 |
1997-10-23 |
University Technology Corporation |
Methods for treating middle and inner ear disorders
|
|
US5861174A
(en)
|
1996-07-12 |
1999-01-19 |
University Technology Corporation |
Temperature sensitive gel for sustained delivery of protein drugs
|
|
US6045528A
(en)
|
1997-06-13 |
2000-04-04 |
Intraear, Inc. |
Inner ear fluid transfer and diagnostic system
|
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6004573A
(en)
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6117949A
(en)
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
DK1024814T3
(da)
|
1997-10-22 |
2008-01-02 |
Jens Ponikau |
Anvendelse af antisvampemidler til topisk behandling af svampe-induceret mucositis
|
|
DE19748763A1
(de)
|
1997-11-05 |
1999-05-06 |
Hans Peter Zenner |
Verwendung von Vasopressin-Antagonisten
|
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
US6649621B2
(en)
|
1997-12-16 |
2003-11-18 |
The United States Of America As Represented By The Secretary Of The Navy |
Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
|
|
US6177434B1
(en)
|
1997-12-16 |
2001-01-23 |
The United States Of America As Represented By The Secretary Of The Navy |
Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
|
|
CA2316248A1
(en)
|
1997-12-23 |
1999-07-01 |
Alliance Pharmaceutical Corp. |
Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
|
|
US6316011B1
(en)
|
1998-08-04 |
2001-11-13 |
Madash, Llc |
End modified thermal responsive hydrogels
|
|
US6509327B1
(en)
|
1998-09-30 |
2003-01-21 |
Alcon Manufacturing, Ltd. |
Compositions and methods for treating otic, ophthalmic and nasal infections
|
|
US6740664B2
(en)
|
1998-09-30 |
2004-05-25 |
Alcon, Inc. |
Methods for treating otic and ophthalmic infections
|
|
JP3787071B2
(ja)
|
1999-02-24 |
2006-06-21 |
ドン ワ ファーマシューティカルズ インダストリー コーポレーティッド リミテッド |
ジクロフェナクナトリウム液状座剤組成物
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
|
PL201130B1
(pl)
|
1999-09-24 |
2009-03-31 |
Alcon Inc |
Kompozycje zawiesinowe zawierające ciprofloksacynę i deksametazon do podawania miejscowego do oczu, uszu lub nosa
|
|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
BR0109162A
(pt)
|
2000-03-14 |
2005-01-11 |
Alcon Inc |
Viscoelásticos para uso na cirurgia do ouvido médio
|
|
US6998137B2
(en)
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
|
US7758888B2
(en)
|
2000-04-21 |
2010-07-20 |
Sol-Gel Technologies Ltd. |
Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US7018645B1
(en)
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
|
AR031135A1
(es)
|
2000-10-10 |
2003-09-10 |
Upjohn Co |
Composiciones de antibiotico topico para el tratamiento de infecciones oculares
|
|
SE0100158D0
(sv)
|
2001-01-19 |
2001-01-19 |
Synphora Ab |
Novel method and composition for local treatment of Meniere´s disease and tinnitus
|
|
US20060269602A1
(en)
|
2001-04-13 |
2006-11-30 |
Dasch James R |
Method of modifying the release profile of sustained release compositions
|
|
US20040022853A1
(en)
|
2001-04-26 |
2004-02-05 |
Control Delivery Systems, Inc. |
Polymer-based, sustained release drug delivery system
|
|
TWI324925B
(en)
|
2001-08-23 |
2010-05-21 |
Novartis Ag |
Ophthalmic composition
|
|
US6488952B1
(en)
|
2001-08-28 |
2002-12-03 |
John P. Kennedy |
Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
|
|
DK1429780T3
(da)
|
2001-09-21 |
2006-02-13 |
|
Fremgangsmåde til behandling af mellemoreinfektioner
|
|
US7001615B1
(en)
|
2001-12-07 |
2006-02-21 |
Alcon, Inc. |
Sustained release ophthalmic, otic and nasal suspension
|
|
DE10162593A1
(de)
|
2001-12-19 |
2003-07-03 |
Menarini Ricerche Spa |
Stabilisierte topische Brivudin-Formulierungen
|
|
AU2003216379A1
(en)
|
2002-02-22 |
2003-09-09 |
Control Delivery Systems, Inc. |
Method for treating otic disorders
|
|
WO2004039328A2
(en)
|
2002-10-29 |
2004-05-13 |
Oregon Health & Science University |
Fludrocortisone treatment for hearing loss
|
|
US20040101506A1
(en)
|
2002-11-25 |
2004-05-27 |
Fust Charles A. |
Composition for the prevention and treatment of inflammation of the ear
|
|
US7220431B2
(en)
|
2002-11-27 |
2007-05-22 |
Regents Of The University Of Minnesota |
Methods and compositions for applying pharmacologic agents to the ear
|
|
US20040204471A1
(en)
|
2003-03-20 |
2004-10-14 |
Pharmacia Corporation |
Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents
|
|
WO2005046438A2
(en)
|
2003-11-06 |
2005-05-26 |
Pluromed, Inc. |
Internal clamp for surgical procedures
|
|
US20060063802A1
(en)
|
2004-03-29 |
2006-03-23 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
US8268866B2
(en)
|
2004-03-29 |
2012-09-18 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
CA2568028A1
(en)
|
2004-05-24 |
2005-12-08 |
Auris Medical, Llc. |
Combined otic aspirator and medication dispenser
|
|
US7858115B2
(en)
|
2004-06-24 |
2010-12-28 |
Idexx Laboratories |
Phospholipid gel compositions for drug delivery and methods of treating conditions using same
|
|
US20060034889A1
(en)
|
2004-08-16 |
2006-02-16 |
Macromed, Inc. |
Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
|
|
US20060046970A1
(en)
|
2004-08-31 |
2006-03-02 |
Insite Vision Incorporated |
Topical otic compositions and methods of topical treatment of prevention of otic infections
|
|
WO2006029074A2
(en)
|
2004-09-03 |
2006-03-16 |
Piedmont Pharmaceuticals, Llc |
Methods for transmembrane treatment and prevention of otitis media
|
|
JP2006111585A
(ja)
|
2004-10-15 |
2006-04-27 |
Mebiol Kk |
徐放性組成物およびその徐放方法
|
|
EP1861161A4
(en)
|
2005-01-24 |
2012-05-16 |
Neurosystec Corp |
APPARATUS AND METHOD FOR DISPENSING THERAPEUTIC AND / OR OTHER AGENTS IN THE INTERNAL EAR AND OTHER FABRICS
|
|
CN101137359B
(zh)
|
2005-03-10 |
2011-01-12 |
3M创新有限公司 |
治疗耳感染的方法
|
|
EP1863453A2
(en)
|
2005-03-29 |
2007-12-12 |
Evonik Röhm GmbH |
Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release
|
|
EP1893174A2
(en)
|
2005-05-10 |
2008-03-05 |
Cytophil, Inc. |
Injectable hydrogels and methods of making and using same
|
|
KR101041843B1
(ko)
|
2005-07-30 |
2011-06-17 |
삼성엘이디 주식회사 |
질화물계 화합물 반도체 발광소자 및 그 제조방법
|
|
US20070048338A1
(en)
|
2005-08-26 |
2007-03-01 |
Ladd Byron S |
Compositions and methods for surface treatment in medical and surgical procedures
|
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
US20080269187A1
(en)
|
2005-09-26 |
2008-10-30 |
Campbell William R |
Methods for Treatment and Prevention of Otitis Media Using Chemical Penetration Enhancers to Facilitate Transmembrane Drug Delivery Into the Middle Ear
|
|
CA2622002A1
(en)
|
2005-09-26 |
2007-04-05 |
Piedmont Pharmaceuticals Llc |
Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear
|
|
KR101271263B1
(ko)
|
2005-09-28 |
2013-06-07 |
아우리스 메디칼 아게 |
내이 장애 치료용 약학 조성물
|
|
US20070110788A1
(en)
|
2005-11-14 |
2007-05-17 |
Hissong James B |
Injectable formulation capable of forming a drug-releasing device
|
|
US20070178051A1
(en)
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
|
CA2655596C
(en)
|
2006-06-27 |
2011-10-25 |
Biovail Laboratories International Srl |
Multiparticulate osmotic delivery system
|
|
JP2010509919A
(ja)
|
2006-11-15 |
2010-04-02 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
内耳細胞の生成
|
|
CN101677822A
(zh)
|
2006-12-11 |
2010-03-24 |
普拉罗美德公司 |
灌注器官止血法
|
|
US20100197800A1
(en)
|
2007-04-23 |
2010-08-05 |
Richard Friedman |
Treatment and/or Prevention of Presbycusis by Modulation of Metabotropic Glutamate Receptor 7
|
|
US7795231B2
(en)
|
2007-10-04 |
2010-09-14 |
Insite Vision Incorporated |
Concentrated aqueous azalide formulations
|
|
EP2278999B1
(en)
|
2008-04-21 |
2025-01-29 |
Dompé farmaceutici S.p.A. |
Auris formulations for treating otic diseases and conditions
|
|
MX2010012397A
(es)
|
2008-05-14 |
2011-03-15 |
Otonomy Inc Star |
Composiciones de corticosteroides de liberacion controlada y metodos para el tratamiento de transtornos oticos.
|
|
WO2009142719A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Massachusetts Institute Of Technology |
Tympanic membrane permeating ear drops and uses thereof
|
|
US8648119B2
(en)
|
2008-05-23 |
2014-02-11 |
Otonomy, Inc. |
Controlled release immunomodulator compositions and methods for the treatment of otic disorders
|
|
US8846770B2
(en)
|
2008-06-18 |
2014-09-30 |
Otonomy, Inc. |
Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
|
|
US8349353B2
(en)
|
2008-06-27 |
2013-01-08 |
Otonomy, Inc. |
Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
|
|
WO2010011466A2
(en)
|
2008-06-27 |
2010-01-28 |
Otonomy, Inc. |
Controlled-release cns modulating compositions and methods for the treatment of otic disorders
|
|
MX2011000545A
(es)
|
2008-07-14 |
2011-02-24 |
Otonomy Inc |
Composiciones de liberacion controlada para la modulacion de apoptosis y metodos para el tratamiento de trastornos oticos.
|
|
US8784870B2
(en)
|
2008-07-21 |
2014-07-22 |
Otonomy, Inc. |
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
|
|
US8318817B2
(en)
|
2008-07-21 |
2012-11-27 |
Otonomy, Inc. |
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
|
|
US8399018B2
(en)
|
2008-07-21 |
2013-03-19 |
Otonomy, Inc. |
Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
|
|
AU2009274137B2
(en)
*
|
2008-07-21 |
2013-10-31 |
Otonomy, Inc. |
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
|
|
US8496957B2
(en)
|
2008-07-21 |
2013-07-30 |
Otonomy, Inc |
Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
|
|
US20100016450A1
(en)
|
2008-07-21 |
2010-01-21 |
Otonomy, Inc. |
Controlled release delivery devices for the treatment of otic disorders
|
|
CN102105133B
(zh)
|
2008-07-21 |
2015-06-17 |
奥德纳米有限公司 |
控制释放型耳结构调节和先天性免疫系统调节组合物以及治疗耳部病症的方法
|
|
CN101664381A
(zh)
|
2009-08-21 |
2010-03-10 |
天津生机集团股份有限公司 |
治疗奶牛乳房炎的原位凝胶缓释制剂的制备方法
|
|
WO2011049958A2
(en)
*
|
2009-10-21 |
2011-04-28 |
Otonomy, Inc. |
Modulation of gel temperature of poloxamer-containing formulations
|
|
JP2013508381A
(ja)
*
|
2009-10-21 |
2013-03-07 |
オトノミ―，インク． |
ポロクサマーを包含する製剤のゲル化温度の調節
|
|
ES2369101B2
(es)
|
2010-05-07 |
2012-08-02 |
Universidade De Santiago De Compostela |
Sistema farmacéutico acuoso para la administración de fármacos en las uñas.
|